2023 Boston Pharmaceutical Symposium

The Boston Chapter first organized the Boston Pharmaceutical Symposium in 2017. Since then, the symposium has become a very successful annual event. The Boston Pharmaceutical Symposium provides a unique venue for sharing statistical applications and research in the biotech-pharma industry, and building connections among all colleagues of the Greater Boston area engaged in statistical practice. We welcome the participation from industry statisticians, academia researchers, university students, and any professionals interested in pharmaceutical statistical topics.

The 2023 Boston Pharmaceutical Symposium will be held at Sanofi’s Campus, in Cambridge MA on October 13, 2023. It’s going to be a full-day event, featuring invited talks, a poster session, network opportunities, and much more. 

All participants in the symposium must register by Friday, October 6. The registration fee covers a light breakfast, lunch, afternoon snacks, and symposium materials. 

Please note: Valid photo ID is required at registration and must be presented to the Sanofi security. Requirements to enter Sanofi buildings are subject to change.

Note to poster presenters: all presenters are expected to register for the symposium and are responsible for printing and transport of the poster. For additional information, please contact ASA.Boston.Pharm.Symposium@gmail.com.

Register Here!

Our speakers

Keynote speakers:


From Traditional Statistics to AI for Clinical Trials and Beyond - A Paradigm Shift by Mark Chang, Founder, Adjunct Professor, AGInception, Boston University


Strategic Innovations in Clinical Development: Unpacking the Statistical Team's Significance by Sammi Tang, Global Head of Biometrics, Co-founder of DahShu, Servier


Invited speakers:


A multi-arm two-stage (MATS) design for proof-of-concept and dose optimization in early-phase oncology trials by Gu Mi, Director, Senior Statistical Project Lead, Sanofi


Optimization of Graphic Multiple Comparison Procedures in Confirmatory Trials by George Kong/Ting Wang, Director, Biostatistics/Sr. Principal Biostatistician, Biogen


Master Protocols in a Pandemic: A Case Study in Statistical Leadership by Lisa LaVange, Professor and Former Chair, Department of Biostatistics, UNC – Chapel Hill


Hybrid platform trial incorporating external data by Wei Wei, Senior manager, Statistics, Takeda


Marginal versus conditional rate estimation for count and recurrent event data with an estimand framework by Sarah Conner, Real World Principal Biostatistician, Vertex


How large-scale simulation is reshaping clinical development strategy: an insider’s guide by Yannis Jemiai, Chief Scientific Officer, Cytel


Enriching Real-World Data Based Studies by Conducting Linkage among Multiple Data Sources by Tianyu Sun, Manager, Real-World Evidence Analytics, Moderna

Thank you to our 2023 Boston Pharmaceutical Symposium sponsors

We thank our colleagues at Sanofi for hosting this event. Financial support from Platinum Sponsor ASA Biopharmaceutical Section; Gold Sponsors Phastar and Servier; Silver Sponsors Cytel, MaxisIT, and Algorics are gratefully acknowledged.

2023 Boston Pharmaceutical Symposium Scientific Committee

Symposium Co-Chair

Jianjun Hua, Dartmouth College

Symposium Co-Chair

Zhaoyang Teng, Servier

Symposium Vice-Chair and Venue Host

Gautier Paux, Sanofi

Symposium Vice-Chair

Xihao Li, UNC-Chapel Hill, formerly Harvard T.H. Chan School of Public Health

Symposium Past-Chair

Kristin Baltrusaitis, Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health

President of Boston Chapter of ASA

         Wenting Cheng, Biogen

Symposium Scientific Committee Members

         Hailu Chen, Biogen

         Brooks Clark, Cytel

         Charmaine Demanuele, Pfizer

         Jimmy Efird, VA CSPCC - Boston

         Lei Gao, Moderna

         Kosalaram Goteti, EMD Serono & ISOP (SxP-SIG)

         Geoffery Grove, Cytel

         Ina Jazic, Vertex

         Kush Kapur, Argenx

         Jun Ke, Astrazeneca

         Hrishikesh Kulkarni, Alexion

         Qing Li, Morphosys

         Jianchang Lin, Takeda

         Charles Liu, Gilead

         Jameson Luks, MaxisIT

         Veena Somayaji, Pfizer

         Disa Yu, Sanofi

         Weidong Zhang, Sana Biotechnology